Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and the prior v3.4.1 note along with a government funding status notice were removed.SummaryDifference0.3%

- Check20 days agoChange DetectedA Notice about government funding status and NIH Clinical Center operations was added. The site version was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded related topic links for Multiple Myeloma and MedlinePlus Genetics on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section has been expanded to include multiple sites in the US and Canada (Massachusetts, New York, North Carolina, Pennsylvania, Texas, Washington, British Columbia, Ontario). The page revision is updated to v3.3.3.SummaryDifference0.7%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.